TrialDiabetes care2010

Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes.

Jacqueline T Jonker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.